טרלג'י אליפטה 184/55/22 מק"ג - Trelegy Ellipta 184/55/22 mcg

× ×ª×× × ×ª×¨××¤×

×××¨×©×

××× ×× ×× × ××¡×¤××	×× ××¨× ××××¤×× 55/22 ××§"× - Anoro ellipta 55/22 mcg ××× ×§×¨×× ××××¤×× 55 ××§"× - Incruse ellipta 55 mcg ××¨××'× ××××¤×× 92 / 55 / 22 ××§"× - Trelegy ellipta 92 / 55 / 22 mcg
×§×××¦× ×¤×¨××§××××××ª (ATC4)	R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
××¨××× ×¤×¢×× (ATC5)	Â Fluticasone FUROATE 184 MCG/INH âR03AL08 Umeclidinium AS BROMIDE 55 MCG/INH âR03AL08 VILANTEROL AS TRIFENATATE 22 MCG/INH âR03AL08
×¦××¨×ª ××ª×	×©×××¤× - INHALATION
×¦××¨×ª ××× ××	POWDER FOR INHALATION PRE-DISPENSED ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	AsthmaTrelegy Ellipta 184/55/22 mcg is indicated for the maintenance treatment of asthma in patients aged 18 years and older. Trelegy Ellipta 184/55/22 mcg should be prescribed for patients who are not adequately controlled on maintenance asthma medication, such as an ICS/LABA.Important Limitations of UseTrelegy Ellipta 184/55/22 mcg is NOT indicated for the relief of acute asthma.Trelegy Ellipta 184/55/22 mcg is not indicated for patients with COPD.
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	Â ×¢××× ××¨××¤× 29.03.2023 Â ××××¨× ××¢××× 29.03.2023 ××××¨× ××¢××× 12.09.2022 ××××¨× ××¢××× 03.08.2022 ××××¨× ××¢××× 03.01.2022

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 29.03.2023 ×¢××× ××¦×¨×× ×× ××××ª Patient information leaflet â29.03.2023 ×¢××× ××¦×¨×× ×¢×¨×××ª ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 29.03.2023

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
××¨××'× ××××¤×× 184/55/22 ××§"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	GLAXO OPERATIONS UK LIMITED ( TRADING AS GLAXO WELLCOME OPERATIONS)
×©× ××¢× ××¨××©××	GLAXO SMITH KLINE (ISRAEL) LTD
×¨××©×××	×ª××¨×× ×××©×: 7/2020. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××

השינוי האחרון נעשה בֹ־11 ביולי 2023 ב־09:45